Vanguard Portfolio Management’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
Other funds holding DYN
Vanguard Portfolio Management's DYN Position: Q3 2026 in Review
Vanguard Portfolio Management increased its Dyne Therapeutics (DYN) stake by 16% in Q3 2026, buying an estimated $14.8M and bringing the position to 4,691,667 shares worth $75.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1573.
Vanguard Portfolio Management first reported a position in DYN in Q1 2026 and has held it in 3 quarters since. The position peaked at $89.9M in Q2 2026. 270 funds tracked by Wall St. Rank hold DYN as of Q3 2026.
- Vanguard Portfolio Management held 4,691,667 shares of Dyne Therapeutics worth $75.6M as of Q3 2026.
- Vanguard Portfolio Management bought 643,239 Dyne Therapeutics shares in Q3 2026, an estimated $14.8M.
- Dyne Therapeutics made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #1573 holding.
- Vanguard Portfolio Management first reported a position in Dyne Therapeutics in Q1 2026 and has held it in 3 quarters since.
- Vanguard Portfolio Management's Dyne Therapeutics position peaked at $89.9M in Q2 2026.
- 270 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.
Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.